510(k) Report

FDA applicant

Iquum, Inc.

Marlborough, MA3 decisions2011–20164 recalls

FDA records 3 decisions for Iquum, Inc. (Marlborough, MA) from 2011 to 2016: 3 510(k) clearances. Most are in product codes OCC (Respiratory Virus Panel Nucleic Acid Assay…) and PGX (Groups A, C And G Beta-Hemolytic Streptococcus…). Its devices cite 8 predicates, 1 of them its own earlier devices. 4 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Iquum, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2016

2011: 12014: 12016: 1
2011high 1 (2011) · low 0 (2012)2026

2026 so far, outlined.

Recalls per year

1in 2021

2015: 12016: 22021: 1
2011high 2 (2016) · low 0 (2011)2026

Class I Class II/III not classified

FIG. 1 — Iquum, Inc. by year, 2011–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Iquum, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report